Psychiatry and Neurology, Neurology · Rochester Hills, MI
NPI
1740230085
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
633 South Blvd E Ste 1300
Rochester Hills, MI, 48307
Phone (248) 299-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$244K
7,652 services
Medicare patients, 2024
1,177
Average age 76
Drug cost, 2024
$2.4M
4,703 prescriptions
Company payments, 2025
$2,327
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Esther L Young was code 99214 (office e&m - established), 910 times for 525 patients. In total Esther L Young billed 7,652 services in 39 codes, and Medicare paid $244K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 910 | 525 | $91.38 | $83K |
| 99223 Hospital E&M - Initial | Facility | 346 | 321 | $132.54 | $46K |
| 99232 Hospital E&M - Subsequent | Facility | 313 | 244 | $62.34 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 172 | 126 | $94.03 | $16K |
| 95816 Neurologic | Facility | 140 | 138 | $42.08 | $5,892 |
| 99205 Office E&M - New | Office | 124 | 124 | $156.73 | $19K |
| 95816 Neurologic | Office | 37 | 33 | $279.63 | $10K |
| 95819 Neurologic | Facility | 31 | 31 | $44.31 | $1,374 |
| 85025 Blood Count | Office | 25 | 23 | $7.31 | $183 |
| 95819 Neurologic | Office | 19 | 17 | $323.17 | $6,140 |
| 99213 Office E&M - Established | Office | 16 | 13 | $63.78 | $1,020 |
| 95720 Neurologic | Facility | 14 | 11 | $164.28 | $2,300 |
By year: 2022 $278K for 8,938 services; 2023 $237K for 7,295 services; 2024 $244K for 7,652 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 25 | 23 | $7.31 | $183 |
Medicare prescription drug claims, 2024
In 2024, the drug Esther L Young prescribed most often to Medicare patients was Donepezil Hcl, with 655 prescriptions and refills. In total Esther L Young wrote 4,703 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 655 | 1,678 | 208 | $11K |
| Memantine Hcl Generic | 536 | 1,383 | 169 | $23K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 212 | 551 | 62 | $9,541 |
| Duloxetine Hcl Generic | 194 | 566 | 68 | $6,296 |
| Gabapentin Generic | 172 | 479 | 59 | $4,908 |
| Levetiracetam Generic | 161 | 393 | 47 | $6,043 |
| Escitalopram Oxalate Generic | 138 | 367 | 44 | $2,080 |
| Quetiapine Fumarate Generic | 127 | 327 | 40 | $2,006 |
| Propranolol Hcl Er Propranolol Hcl | 126 | 356 | 40 | $9,264 |
| Primidone Generic | 104 | 283 | 31 | $6,992 |
| Sertraline Hcl Generic | 80 | 239 | 28 | $1,190 |
| Topiramate Generic | 75 | 201 | 24 | $1,582 |
| Pregabalin Generic | 71 | 178 | 21 | $2,172 |
| Sumatriptan Succinate Generic | 71 | 132 | 23 | $1,825 |
| Ropinirole Er Ropinirole Hcl | 70 | 200 | 21 | $31K |
Brand drugs: - claims; generic drugs: 4,281 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Esther L Young $2,327 ($2,327 in general payments such as food, travel and fees) from 26 companies. The largest payer was Novartis Pharmaceuticals Corporation with $521.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 62 | $521 |
| Abbvie Inc. ABBV | 33 | $496 |
| Celgene Corporation BMY | 16 | $197 |
| Pfizer Inc. PFE | 8 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $106 |
| Noctrix Health, Inc. | 1 | $101 |
| EMD Serono, Inc. MRK.DE | 4 | $88.88 |
| Amgen Inc. AMGN | 3 | $73.33 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $70.81 |
| Lundbeck LLC | 3 | $64.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.